GOLD star treatment for COPD
The two main strategies aim to reduce symptoms and the risk of exacerbation
2nd July 2015
As our appreciation of the role COPD plays in increasing morbidity grows, so too does the range of new inhalers on the market.
The Global Initiative for Obstructive Lung Disease (GOLD) defines chronic obstructive pulmonary disease as a common preventable and treatable disease, characterised by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases.1
The two main management strategies are aimed at reducing symptoms and reducing